ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Rapamune 0.5 mg, überzogene Tabletten - 100 Tablette(n)
55804009 Pfizer AG
Rapamune 0.5 mg, überzogene Tabletten14.12.2001
  15.02.2011
Sirolimus (L04AA10)19.06.2006
WHO-DDD 
07.15.100 Tablette(n)
07.15. 
B  
No 
IPCI
PR  
k.A.PR
  
7680558040098Biotechnologika
  
Composition
sirolimusum 0.5 mg, poloxamerum 188, lactosum monohydricum 86.4 mg, macrogolum 8000, magnesii stearas, talcum, macrogolum 20'000, glyceroli mono-oleas, lacca, calcii sulfas anhydricus, cellulosum microcristallinum, saccharum 213.7 mg, povidonum K 29-32, int-rac-alpha-tocopherylis acetas, E 171, E 172 (flavum), E 172 (nigrum), E 172 (rubrum), cera carnauba, Drucktinte: lacca, E 172 (rubrum), propylenglycolum, simeticonum, pro compresso obducto.
Packungsbestandteile
überzogene Tabletten 
 
Active AgentDose
Sirolimus0.5 mg
BAG: Active AgentDose
Sirolimus0.5 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Nigrum)  
(Rubrum)  
Calcii Sulfas Anhydricus  
Cellulosum Microcristallinum  
Cera Carnauba  
E 171 color.
E 172 color.
Glyceroli Mono-Oleas  
Int-Rac-Alpha-Tocopherylis Acetas  
Lacca Drucktinte
Lactose Monohydrate86.4 mg 
Macrogol20000  
Magnesii Stearas  
Poloxamer188  
Povidonum K29-32 
Pro Compresso Obducto  
Propylenglycol  
Saccharum213.7 mg 
Simeticone  
Talcum  
 
Source
Data was imported : 06.11.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home